Nobuhiko Oridate

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Ravindra Uppaluri, Robert I. Haddad, Yungan Tao et al. · New England Journal of Medicine · 2025 · 266 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Involvement of Reactive Oxygen Species in N-(4-Hydroxyphenyl)retinamide-Induced Apoptosis in Cervical Carcinoma Cells

Nobuhiko Oridate, Seigo Suzuki, Masahiro Higuchi et al. · JNCI Journal of the National Cancer Institute · 1997 · 226 citations · Full text

Life Sciences, Toxicology, Apoptosis +12

Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-Hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells

Seigo Suzuki, Masahiro Higuchi, Rita J. Proske et al. · Oncogene · 1999 · 144 citations

Life Sciences, Cell Biology, Oncology +16

Superselective high‐dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses

Akihiro Homma, Nobuhiko Oridate, Fumiyuki Suzuki et al. · Cancer · 2009 · 126 citations · Full text

Medicine, Oncology, Radiation Oncology +13